These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 4811325)

  • 1. Sequential changes in blood preserved with citrate-phosphate-dextrose.
    Limbird TJ; Silver D
    Surg Gynecol Obstet; 1974 Mar; 138(3):401-5. PubMed ID: 4811325
    [No Abstract]   [Full Text] [Related]  

  • 2. Citrate phosphate dextrose (CPD) anticoagulant in blood transfusion.
    McCullough J; Weiblen BJ
    Minn Med; 1973 Nov; 56(11):980-2. PubMed ID: 4756991
    [No Abstract]   [Full Text] [Related]  

  • 3. Citrate-phosphate-dextrose: an improved anticoagulant preservative solution for human blood.
    Gibson JG
    Vox Sang; 1967 Jul; 13(1):106-7. PubMed ID: 6035803
    [No Abstract]   [Full Text] [Related]  

  • 4. 2,3-diphosphoglycerate in red cells stored in acid-citrate-dextrose and citrate-phosphate-dextrose: implications regarding delivery of oxygen.
    Shafer AW; Tague LL; Welch MH; Guenter CA
    J Lab Clin Med; 1971 Mar; 77(3):430-7. PubMed ID: 5553727
    [No Abstract]   [Full Text] [Related]  

  • 5. Manufacture of red cells in additive solution from whole blood refrigerated for 5 days or remanufactured from red cells stored in plasma.
    Wiltshire M; Cardigan R; Thomas S
    Transfus Med; 2010 Dec; 20(6):383-91. PubMed ID: 20681977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2,3-Diphosphoglycerate levels in CPD-preserved bank blood.
    Schweizer O; Howland WS
    Anesth Analg; 1974; 53(4):516-9. PubMed ID: 4858306
    [No Abstract]   [Full Text] [Related]  

  • 7. Whole blood storage in citrate and phosphate solutions containing half-strength trisodium citrate: cellular and biochemical studies.
    Mishler JM; Darley JH; Cederholm-Williams S; Wright G
    J Pathol; 1978 Mar; 124(3):125-39. PubMed ID: 722376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of pH on blood preservation in acid-citrate and citrate-phosphate dextrose.
    Kulkarni SK; Baxi AJ; Bhatia HM
    Indian J Med Res; 1980 Nov; 72():725-30. PubMed ID: 7203576
    [No Abstract]   [Full Text] [Related]  

  • 9. Further evaluation of CPD.
    Kevy SV
    Vox Sang; 1967 Jul; 13(1):114-8. PubMed ID: 6035807
    [No Abstract]   [Full Text] [Related]  

  • 10. Hemoglobin function in stored blood. IX. Preservative with pH to maintain red blood cell 2,3-DPG (function) and ATP (viability).
    Dawson RB; Loken MR; Crater DH
    Transfusion; 1972; 12(1):46-52. PubMed ID: 5009584
    [No Abstract]   [Full Text] [Related]  

  • 11. Lipid peroxidation compared in stored whole blood with various nutrient-anticoagulant solutions.
    Knight JA; Searles DA; Blaylock RC
    Ann Clin Lab Sci; 1993; 23(3):178-83. PubMed ID: 8323251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes in thrombocyte volume in thrombocyte concentrates prepared from blood preserved with ACD or CPD as anticoagulants].
    Flego I; Nazor A; Grgicević D; Lupret L; Marchiotti I
    Lijec Vjesn; 1988; 110(3-4):75-8. PubMed ID: 3398688
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of citrate-phosphate-dextrose on certain metabolic changes in human red cells during preservation.
    Datta MC; Ghosh SK; Swarup-Mitra S
    Bull Calcutta Sch Trop Med; 1968 Jan; 16(1):5-7. PubMed ID: 5713694
    [No Abstract]   [Full Text] [Related]  

  • 14. [Problems of massive transfusion with ACD (acid citrate, dextrose) blood].
    Stoeckel H; Stober B
    Z Prakt Anasth; 1970 Aug; 5(4):237-50. PubMed ID: 4256233
    [No Abstract]   [Full Text] [Related]  

  • 15. Morphological classification by scanning electron microscopy of erythrocytes stored at 4 degrees C in citrate-phosphate-dextrose anticoagulant.
    Truter EJ; Murray PW
    Med Lab Sci; 1990 Apr; 47(2):113-9. PubMed ID: 2381268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Citrate acid dextrose and citrate-phosphate-dextrose anticoagulant solutions].
    Combrisson A
    Rev Fr Transfus; 1971 Dec; 14(4):483-9. PubMed ID: 5153041
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparative studies on ACD whole preserved blood, erythrocyte concentrates and erythrocyte resuspension].
    Hoffmann D; Altenbrunn J; Raderecht HJ
    Z Gesamte Inn Med; 1967 Jan; 22(2):51-7. PubMed ID: 5585467
    [No Abstract]   [Full Text] [Related]  

  • 18. [On 566 cardiac operations under extracorporeal circulation carried out with blood preserved for 18 to 48 hours in acid citrate dextrose (A.C.D.) solution. (Study of chemical and enzymatic modifications and coagulation disorders)].
    Revol L; Termet H; Vittoz P; Thouverez JP; Mikaeloff P; Counitchansky M
    Bibl Haematol; 1968; 29():739-45. PubMed ID: 5728117
    [No Abstract]   [Full Text] [Related]  

  • 19. [Proceedings: The optimal blood conserve (author's transl)].
    Seidl S
    Thoraxchir Vask Chir; 1973 Oct; 21(5):337-43. PubMed ID: 4544416
    [No Abstract]   [Full Text] [Related]  

  • 20. The in vitro quality of washed, prestorage leucocyte-depleted red blood cell concentrates.
    Weisbach V; Riego W; Strasser E; Zingsem J; Ringwald J; Zimmermann R; Eckstein R
    Vox Sang; 2004 Jul; 87(1):19-26. PubMed ID: 15260818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.